Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 125 of 125 entries
Sorted by: Best Match Show Resources per page
Solid organ transplant-specific antibiogram in a tertiary pediatric hospital in Canada.

Pediatric transplantation

Kitano T, Science M, Nalli N, Timberlake K, Allen U, Teoh CW, Campigotto A.
PMID: 33528088
Pediatr Transplant. 2021 Jun;25(4):e13980. doi: 10.1111/petr.13980. Epub 2021 Feb 02.

SOT recipients are more vulnerable to infections with antimicrobial-resistant organisms, and therefore, it may be useful for transplant centers to create transplant-specific antibiograms to direct empirical antimicrobial regimens and monitor trends in antimicrobial resistance. SOT-specific antibiograms were created using...

Cite
Kitano T, Science M, Nalli N, et al. Solid organ transplant-specific antibiogram in a tertiary pediatric hospital in Canada. Pediatr Transplant. 2021;25(4):e13980doi: 10.1111/petr.13980.
Kitano, T., Science, M., Nalli, N., Timberlake, K., Allen, U., Teoh, C. W., & Campigotto, A. (2021). Solid organ transplant-specific antibiogram in a tertiary pediatric hospital in Canada. Pediatric transplantation, 25(4), e13980. https://doi.org/10.1111/petr.13980
Kitano, Taito, et al. "Solid organ transplant-specific antibiogram in a tertiary pediatric hospital in Canada." Pediatric transplantation vol. 25,4 (2021): e13980. doi: https://doi.org/10.1111/petr.13980
Kitano T, Science M, Nalli N, Timberlake K, Allen U, Teoh CW, Campigotto A. Solid organ transplant-specific antibiogram in a tertiary pediatric hospital in Canada. Pediatr Transplant. 2021 Jun;25(4):e13980. doi: 10.1111/petr.13980. Epub 2021 Feb 02. PMID: 33528088.
Copy Download .nbib Format: NLM
Level of kisspeptin-10 in patients with multiple sclerosis and the association between third ventricle diameter size and vitamin D level.

Physiology international

Akdag T, Uca AU, Altas M, Odabas FO, Aktas F.
PMID: 34138749
Physiol Int. 2021 Jun 16; doi: 10.1556/2060.2021.00179. Epub 2021 Jun 16.

OBJECTIVE: Multiple sclerosis (MS) is a chronic and progressive neurological disease affecting the central nervous system (CNS). Some studies report an association between MS pathogenesis and cytokines. Here, we aimed to determine and evaluate serum kisspeptin-10 level in MS...

Cite
Akdag T, Uca AU, Altas M, et al. Level of kisspeptin-10 in patients with multiple sclerosis and the association between third ventricle diameter size and vitamin D level. Physiol Int. 2021;doi: 10.1556/2060.2021.00179.
Akdag, T., Uca, A. U., Altas, M., Odabas, F. O., & Aktas, F. (2021). Level of kisspeptin-10 in patients with multiple sclerosis and the association between third ventricle diameter size and vitamin D level. Physiology international, . https://doi.org/10.1556/2060.2021.00179
Akdag, T, et al. "Level of kisspeptin-10 in patients with multiple sclerosis and the association between third ventricle diameter size and vitamin D level." Physiology international vol. (2021). doi: https://doi.org/10.1556/2060.2021.00179
Akdag T, Uca AU, Altas M, Odabas FO, Aktas F. Level of kisspeptin-10 in patients with multiple sclerosis and the association between third ventricle diameter size and vitamin D level. Physiol Int. 2021 Jun 16; doi: 10.1556/2060.2021.00179. Epub 2021 Jun 16. PMID: 34138749.
Copy Download .nbib Format: NLM
Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Khan SN, Shaheen F, Aleem U, Sheikh S, Tamfu AN, Ashraf S, Ul-Haq Z, Ullah S, Wahab AT, Choudhary MI, Jahan H.
PMID: 34666184
Eur J Pharm Sci. 2022 Jan 01;168:106045. doi: 10.1016/j.ejps.2021.106045. Epub 2021 Oct 16.

18β-Glycyrrhetinic acid (18β-GA) is known for several biological activities, and has been the focus of extensive research for the development of therapeutic agents. In the current study, 18β-GA-peptide conjugates 2-11 were evaluated for their in vitro α-glucosidase inhibitory and...

Cite
Khan SN, Shaheen F, Aleem U, et al. Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation. Eur J Pharm Sci. 2021;168:106045doi: 10.1016/j.ejps.2021.106045.
Khan, S. N., Shaheen, F., Aleem, U., Sheikh, S., Tamfu, A. N., Ashraf, S., Ul-Haq, Z., Ullah, S., Wahab, A. T., Choudhary, M. I., & Jahan, H. (2022). Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 168106045. https://doi.org/10.1016/j.ejps.2021.106045
Khan, Sadiq Noor, et al. "Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 168 (2022): 106045. doi: https://doi.org/10.1016/j.ejps.2021.106045
Khan SN, Shaheen F, Aleem U, Sheikh S, Tamfu AN, Ashraf S, Ul-Haq Z, Ullah S, Wahab AT, Choudhary MI, Jahan H. Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation. Eur J Pharm Sci. 2022 Jan 01;168:106045. doi: 10.1016/j.ejps.2021.106045. Epub 2021 Oct 16. PMID: 34666184.
Copy Download .nbib Format: NLM
Relationship Between the Ratio of Acceleration Time/Ejection Time and Mortality in Patients With High-Gradient Severe Aortic Stenosis.

Journal of the American Heart Association

Altes A, Thellier N, Bohbot Y, Ringle Griguer A, Verdun S, Levy F, Castel AL, Delelis F, Mailliet A, Tribouilloy C, Maréchaux S.
PMID: 34845911
J Am Heart Assoc. 2021 Dec 07;10(23):e021873. doi: 10.1161/JAHA.121.021873. Epub 2021 Nov 30.

Background The ratio of acceleration time/ejection time (AT/ET) is a simple and reproducible echocardiographic parameter that integrates aortic stenosis severity and its consequences on the left ventricle. No study has specifically assessed the prognostic impact of AT/ET on outcome...

Cite
Altes A, Thellier N, Bohbot Y, et al. Relationship Between the Ratio of Acceleration Time/Ejection Time and Mortality in Patients With High-Gradient Severe Aortic Stenosis. J Am Heart Assoc. 2021;10(23):e021873doi: 10.1161/JAHA.121.021873.
Altes, A., Thellier, N., Bohbot, Y., Ringle Griguer, A., Verdun, S., Levy, F., Castel, A. L., Delelis, F., Mailliet, A., Tribouilloy, C., & Maréchaux, S. (2021). Relationship Between the Ratio of Acceleration Time/Ejection Time and Mortality in Patients With High-Gradient Severe Aortic Stenosis. Journal of the American Heart Association, 10(23), e021873. https://doi.org/10.1161/JAHA.121.021873
Altes, Alexandre, et al. "Relationship Between the Ratio of Acceleration Time/Ejection Time and Mortality in Patients With High-Gradient Severe Aortic Stenosis." Journal of the American Heart Association vol. 10,23 (2021): e021873. doi: https://doi.org/10.1161/JAHA.121.021873
Altes A, Thellier N, Bohbot Y, Ringle Griguer A, Verdun S, Levy F, Castel AL, Delelis F, Mailliet A, Tribouilloy C, Maréchaux S. Relationship Between the Ratio of Acceleration Time/Ejection Time and Mortality in Patients With High-Gradient Severe Aortic Stenosis. J Am Heart Assoc. 2021 Dec 07;10(23):e021873. doi: 10.1161/JAHA.121.021873. Epub 2021 Nov 30. PMID: 34845911.
Copy Download .nbib Format: NLM
Arthroscopic Debridement and Arthrolysis for the Treatment of Advanced Kienböck's Disease: 18-Month and 5-Year Postoperative Results.

Journal of wrist surgery

Ayik O, Demirel M, Turgut N, Altas O, Durmaz H.
PMID: 34381629
J Wrist Surg. 2021 Aug;10(4):280-285. doi: 10.1055/s-0040-1722570. Epub 2021 Jan 22.

No abstract available.

Cite
Ayik O, Demirel M, Turgut N, et al. Arthroscopic Debridement and Arthrolysis for the Treatment of Advanced Kienböck's Disease: 18-Month and 5-Year Postoperative Results. J Wrist Surg. 2021;10(4):280-285doi: 10.1055/s-0040-1722570.
Ayik, O., Demirel, M., Turgut, N., Altas, O., & Durmaz, H. (2021). Arthroscopic Debridement and Arthrolysis for the Treatment of Advanced Kienböck's Disease: 18-Month and 5-Year Postoperative Results. Journal of wrist surgery, 10(4), 280-285. https://doi.org/10.1055/s-0040-1722570
Ayik, Omer, et al. "Arthroscopic Debridement and Arthrolysis for the Treatment of Advanced Kienböck's Disease: 18-Month and 5-Year Postoperative Results." Journal of wrist surgery vol. 10,4 (2021): 280-285. doi: https://doi.org/10.1055/s-0040-1722570
Ayik O, Demirel M, Turgut N, Altas O, Durmaz H. Arthroscopic Debridement and Arthrolysis for the Treatment of Advanced Kienböck's Disease: 18-Month and 5-Year Postoperative Results. J Wrist Surg. 2021 Aug;10(4):280-285. doi: 10.1055/s-0040-1722570. Epub 2021 Jan 22. PMID: 34381629; PMCID: PMC8328547.
Copy Download .nbib Format: NLM
Showing 121 to 125 of 125 entries